HYPD
Hyperion DeFi·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HYPD Profile
Hyperion Defi, Inc.
A clinical stage biopharmaceutical company
23461 South Pointe Drive, Suite 390, Laguna Hills, CA 92653
--
Hyperion DeFi, Inc., formerly known as PGP Holdings V, Inc., was incorporated under the laws of Florida on March 12, 2014 and re-incorporated in Delaware as Eyenovia, Inc., a clinical-stage biopharmaceutical company that has developed a range of ophthalmic products using its patented piezoelectric printing technology to provide microtherapy for ocular skin. This microdosing technology has the potential to replace traditional high-dose applications (such as the delivery of conventional eye drops of 30-50μL), which are often overdosed or underdosed when used for topical application of ophthalmic therapeutic agents. They believe that their micro-therapeutic product candidates may be able to achieve pharmacological effects similar to traditional high-dose applications while reducing the adverse effects associated with these technologies.
